Foote Cone & Belding

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Quick Thinkers
Matt Gunther, Rich Gagnon, Jan Weinstein, Matt Levy and Jane Jovanovic

Imagine you are advertising to a potential customer who is forgetful, difficult to deal with and simply unable to focus. That is precisely the condition of adult sufferers of Attention Deficit Disorder, the target audience for Eli Lilly & Co.’s new Strattera, the first ADD drug indicated for adults. Pinpointing this hard-to-reach target was only half of Foote Cone & Belding’s mission—it also had to introduce Strattera to parents of ADD children, a well-developed but highly competitive segment.

“It was really one launch to two target markets at the same time,” says Jan Weinstein, senior vp/group media director.




AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in